NCT00666341View on ClinicalTrials.gov

Dose-Response-Study With a Recombinant Cocktail of Phleum (rPhleum) Allergens

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

May 31, 2010

Conditions
Type I-Allergy
Interventions
DRUG

placebo

Placebo: Al(OH)3-Placebos with histamine-dihydrochloride analogue Allergen-Adsorbate rPhleum strengthes 1 to 4.

BIOLOGICAL

rPhleum

Cocktail of recombinant major allergens of Phleum pratense (timothy grass) with strength 1 (20 μg)

BIOLOGICAL

rPhleum

Cocktail of recombinant major allergens of Phleum pratense (timothy grass) with strength 2 (40 μg)

BIOLOGICAL

rPhleum

Cocktail of recombinant major allergens of Phleum pratense (timothy grass) with strength 3 (80 μg)

BIOLOGICAL

rPhleum

Cocktail of recombinant major allergens of Phleum pratense (timothy grass) with strength 4 (120 μg)

Trial Locations (1)

68167

Prof. Dr. med. Ludger Klimek, Wiesbaden

All Listed Sponsors
lead

Allergopharma GmbH & Co. KG

INDUSTRY

NCT00666341 - Dose-Response-Study With a Recombinant Cocktail of Phleum (rPhleum) Allergens | Biotech Hunter | Biotech Hunter